Medicquant Aps
Our vision is to enable rapid and local tests for anticoagulants at the point-of-care to benefit patients. Currently, there is no readily available solutions to address blood levels of anticoagulants called Direct Oral Anticoagulants (DOACs) at the point-of-care. We have developed a novel technology, chip and instrument that can detect anticoagulants, directly from whole blood within only 10 minutes. The elegant simplicity of our solution will potentially be readily available at the point of care.
7-day free trial · no credit card
Verified contacts
9
available on Kipplo
LinkedIn employees
14
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 9 verified contacts at Medicquant Aps
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
9 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Medicquant Aps
5 distinct titles indexed · top 5 shown.
- 1ceo & co-founder
- 1chief technology officer, co-founder
- 1director hardware development
- 1r & d scientist
- 1research and development scientist
Sign up to unlock all 9 contacts at Medicquant Aps
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 9 verified contacts at Medicquant Aps
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.